HIGHLIGHTS
- who: Rosario Hervu00e1s-Salcedo and collaborators from the Germany University of Louisville, United States have published the article: Improved efficacy of mesenchymal stromal cells stably expressing CXCR4 and IL-10 in a xenogeneic graft versus host disease mouse model, in the Journal: (JOURNAL)
- what: The authors demonstrate that, compared to WT-MSCs, MSCs stably expressing both CXCR4 and IL-10 exert enhanced therapeutic effects in a humanized model of GvHD, strongly suggesting that these cells will constitute a novel advanced therapy medicinal product with enhanced anti-GvHD therapeutic properties. Taken together, the study demonstrates that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.